Lv6
1718 积分 2023-10-16 加入
NSD2 serves as a potential prognostic biomarker in mantle cell lymphoma
33分钟前
待确认
Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines
2个月前
已完结
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
2个月前
已完结
Concurrent TP53 and CDKN2A Gene Aberrations in Newly Diagnosed Mantle Cell Lymphoma Correlate with Chemoresistance and Call for Innovative Upfront Therapy
2个月前
已完结
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials
2个月前
已完结
Mantle cell lymphoma in 2022—A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments
2个月前
已完结
Establishment and characterization of a new mantle cell lymphoma cell line with a NOTCH2 mutation, Arbo
2个月前
已完结
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma
2个月前
已完结
ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients
2个月前
已完结
Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in TP53 -mutated disease
2个月前
已完结
皖公网安备34019202002308
